SCHEMBL5657703

SCHEMBL5657703

CCOc1ccc(NC(C)=O)c(OC)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.66
HSD17B1 P14061 1/20 0.58
HSD17B2 P37059 1/20 0.58
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
CYP1A2 P05177 2/20 0.55
LMNA P02545 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPT P10636 4/20 0.54
PKM P14618 1/20 0.54
TAS1R3 Q7RTX0 1/20 0.53
TAS1R1 Q7RTX1 1/20 0.53
EPHX1 P07099 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
GAA P10253 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
KDM4E B2RXH2 1/20 0.51
CYP1A1 P04798 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10789373 0.91 TDP1 (0.58) ALDH1A1KMT2AMEN1CYP1A2LMNA
SCHEMBL2191052 0.85 HSD17B1 (0.75) ALDH1A1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL30622065 0.85 HSD17B1 (0.75) ALDH1A1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL7349883 0.84 ALDH1A1 (0.55) ALDH1A1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL13495708 0.84 ALDH1A1 (0.51) ALDH1A1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL10889367 0.83 ALDH1A1 (0.52) ALDH1A1HSD17B1HSD17B2KMT2AMEN1
SCHEMBL7501359 0.82 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1CYP1A2LMNA
SCHEMBL2111071 0.81 KMT2A (0.58) ALDH1A1KMT2AMEN1CYP1A2LMNA
SCHEMBL10889926 0.81 KMT2A (0.58) ALDH1A1KMT2AMEN1CYP1A2LMNA
SCHEMBL9182141 0.81 EPHX1 (0.74) ALDH1A1KMT2AMEN1CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR ALDH1A1 1365/4885HSD17B1 3397/4885HSD17B2 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.